tldrdailynews.com logo

FDA approves innovative drug for menopausal hot flashes.

1 min read
Source: FDA.gov
FDA approves innovative drug for menopausal hot flashes.
Photo: FDA.gov
TL;DR

The FDA has approved Veozah, an oral medication that targets the neural activity causing hot flashes during menopause. It is the first neurokinin 3 receptor antagonist approved by the FDA to treat moderate to severe hot flashes from menopause. Veozah is not a hormone and is an additional safe and effective treatment option for women who cannot take hormone therapies. The most common side effects of Veozah include abdominal pain, diarrhea, insomnia, back pain, hot flush, and elevated hepatic transaminases.

Topics:businesshealth#fda#health#hot-flashes#menopause#neurokinin-3-receptor-antagonist#veozah
Share this article
  1. FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause  FDA.gov
  2. FDA green lights a new type of drug for menopausal hot flashes  CNN
  3. F.D.A. Approves New Drug to Treat Hot Flashes  The New York Times
  4. New menopause drug for hot flashes gets FDA approval  The Associated Press
  5. US FDA approves Astellas Pharma pill for menopause hot flashes  Reuters
  6. View Full Coverage on Google News

Want the full story? Read the original reporting

Read on FDA.gov